Physician profile
Alec E Wilson
NPI 1801270327
$4,485.17
in general payments reported to CMS, 2019-2025
36 companies · $1,168 in 2025
The $1,168 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $189 · 2021: $409 · 2022: $712 · 2023: $837 · 2024: $842 · 2025: $1,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,759 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,758.73 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $521.92 | 2021-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $385.37 | 2019-2023 | Rezum Generator, Spaceoar Vue System - 10ml |
| Olympus America INC. | $289.15 | 2019-2025 | Itind System |
| Abbvie INC. | $274.48 | 2022-2025 | Botox |
| Sumitomo Pharma America, INC. | $233.22 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $224.20 | 2021-2025 | Xyosted |
| Myriad Genetic Laboratories, INC. | $202.50 | 2021-2025 | Prolaris |
| Pfizer INC. | $193.34 | 2022-2025 | |
| Procept Biorobotics Corporation | $187.80 | 2022-2025 | Aquabeam System |
| Urogen Pharma, INC. | $186.21 | 2022-2025 | Jelmyto |
| Allergan, INC. | $147.70 | 2020-2022 | |
| Biotissue Holdings INC. | $147.30 | 2025 | |
| Teleflex LLC | $136.50 | 2023 | Urolift |
| Axonics, INC. | $131.97 | 2021-2024 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $119.21 | 2021-2025 | Keytruda |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $113.21 | 2025 | Tlando |
| Laborie Medical Technologies Corp. | $89.58 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| 180 Medical, INC. | $86.55 | 2022-2023 | |
| Endo USA, INC. | $80.42 | 2024-2025 | Xiaflex |
| Halozyme INC | $78.43 | 2023 | |
| Smith+Nephew, INC. | $78.42 | 2023-2024 | Stravix, Grafix Pl, Grafix |
| Endo Pharmaceuticals INC. | $77.04 | 2021-2023 | Xiaflex |
| Coloplast Corp | $66.41 | 2022-2024 | Speedicath |
| Dendreon Pharmaceuticals LLC | $65.23 | 2023-2025 | Provenge |
| Blue Earth Diagnostics | $57.45 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.23 | 2024-2025 | |
| Tolmar Pharmaceuticals, INC. | $39.93 | 2022 | |
| Tolmar, INC. | $39.14 | 2023-2025 | Jatenzo, Eligard |
| Srs Medical Systems, INC. | $36.56 | 2020 | |
| Civco Medical Instruments | $24.35 | 2024 | |
| Tempus Ai, INC | $23.79 | 2024 | |
| Genzyme Corporation | $22.43 | 2021 | |
| Immunitybio, INC. | $20.05 | 2025 | |
| Novartis Pharmaceuticals Corporation | $17.28 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $16.17 | 2021 | |
| Photocure INC | $14.63 | 2024 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alec Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.